331240-24-5

Basic information

• Product Name: N-(2,4-dimethoxyphenyl)-4-nitrobenzenesulfonamide
• Synonyms: N-(2,4-dimethoxyphenyl)-4-nitrobenzenesulfonamide
• CAS NO: 331240-24-5
• Molecular Formula: C14H14N2O6S
• Molecular Weight: 338.33576
• Mol File: 331240-24-5.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: N-(2,4-dimethoxyphenyl)-4-nitrobenzenesulfonamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(2,4-dimethoxyphenyl)-4-nitrobenzenesulfonamide(331240-24-5)
• EPA Substance Registry System: N-(2,4-dimethoxyphenyl)-4-nitrobenzenesulfonamide(331240-24-5)

Safety Data

• Hazardous Substances Data: 331240-24-5(Hazardous Substances Data)

Upstream product

• 98-74-8 4-Nitrobenzenesulfonyl chloride 
• 73901-01-6 p-nitrobenzenesulfonyl azide 
• 151-10-0 1,3-Dimethoxybenzene 
• 2735-04-8 2,4-Dimethoxyaniline 

Relevant articles and documents

Regioselective C-H Amidation of (Alkyl)arenes by Iron(II) Catalysis

A nondirected amidation reaction of aromatic C-H bond was developed under iron(II) catalysis, using sulfonyl azides as the nitrogen source. The reaction displayed a broad substrate scope and good regioselectivities in the aspects of aromatic ring vs alkyl

INHIBITORS OF RAC1 AND USES THEREOF FOR TREATING CANCERS

The present invention concerns a compound having the following formula (I): wherein: - A is in particular -N(R'a)-C(=O)-R, R'a being H or a (C1-C6)alkyl group, and R being preferably a group having the following formula (II): - X is in particular chosen from the group consisting of: -SO2-N(R'b)-, R'b being H or a (C1-C6)alkyl group, -N(R"b)-SO2-, R"b being H or a (C1-C6)alkyl group, -CO-NH-, and -NH-CO-, for use for the treatment of cancers, such as metastatic cancers.

INHIBITORS OF RAC1 AND USES THEREOF FOR INDUCING BRONCHODILATATION

The present invention concerns a compound having the following formula (I): wherein: - A is in particular -N(R'a)-C(=O)-R, R'a being H or a (C1-C6)alkyl group, and R being preferably a group having the following formula (II): - X is in particular chosen from the group consisting of: -SO2-N(R'b)-, R'b being H or a (C1-C6)alkyl group, -N(R"b)-SO2-, R"b being H or a (C1-C6)alkyl group, -CO-NH-, and -NH-CO-, for use for the treatment of pathologies characterized by bronchoconstriction, such as asthma.